Kayne Anderson Rudnick Investment Management LLC Sells 26,149 Shares of National Research Co. (NASDAQ:NRC)

Kayne Anderson Rudnick Investment Management LLC reduced its holdings in shares of National Research Co. (NASDAQ:NRC - Free Report) by 0.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,033,427 shares of the company's stock after selling 26,149 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned about 12.92% of National Research worth $53,510,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in NRC. PNC Financial Services Group Inc. grew its holdings in shares of National Research by 2,250.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company's stock valued at $27,000 after purchasing an additional 1,463 shares during the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of National Research during the fourth quarter valued at about $50,000. FMR LLC increased its holdings in shares of National Research by 397.3% in the third quarter. FMR LLC now owns 2,944 shares of the company's stock worth $67,000 after buying an additional 2,352 shares during the period. Signaturefd LLC increased its holdings in shares of National Research by 613.3% in the fourth quarter. Signaturefd LLC now owns 4,173 shares of the company's stock worth $74,000 after buying an additional 3,588 shares during the period. Finally, Quadrant Capital Group LLC lifted its stake in shares of National Research by 219.3% in the 4th quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company's stock valued at $88,000 after acquiring an additional 3,438 shares during the last quarter. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Trading Up 0.3 %

National Research stock traded up $0.03 during trading hours on Friday, reaching $10.72. The company had a trading volume of 75,050 shares, compared to its average volume of 93,713. The firm has a market cap of $245.98 million, a price-to-earnings ratio of 10.21 and a beta of 0.41. National Research Co. has a 12-month low of $9.76 and a 12-month high of $35.81. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The company has a 50-day moving average price of $13.33 and a 200 day moving average price of $16.55.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.12 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.48 annualized dividend and a dividend yield of 4.48%. National Research's payout ratio is presently 45.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.